25 years on from the release of the first draft of the human genome, the Genomics Futures podcast series explores what the future of genomics will be like in 2050.<br />Across 6 episodes, we explore the themes and topics that arose from discussions that took place during the Genomics Futures workshops, hosted by the Wellcome Sanger Institute and Wellcome in 2025.<br /><br />The aim of these podcasts is not to showcase definitive thoughts, but to explore the possibilities of genomics in twenty five years’ time, hence why some speakers may contradict each other. The views expressed in these podcasts are of the speakers alone.<br /><br />Further information about the workshops including further outputs can be found here: <a href="https://www.sanger.ac.uk/innovation/sanger-genomics-futures-series/" target="_blank" rel="noreferrer noopener">https://www.sanger.ac.uk/innovation/sanger-genomics-futures-series/</a><br /><br />This podcast is produced by the Wellcome Sanger Institute.
Genomics Futures
Claim This Podcastby Genomics Futures
Podcast Overview
25 years on from the release of the first draft of the human genome, the Genomics Futures podcast series explores what the future of genomics will be like in 2050.<br />Across 6 episodes, we explore the themes and topics that arose from discussions that took place during the Genomics Futures workshops, hosted by the Wellcome Sanger Institute and Wellcome in 2025.<br /><br />The aim of these podcasts is not to showcase definitive thoughts, but to explore the possibilities of genomics in twenty five years’ time, hence why some speakers may contradict each other. The views expressed in these podcasts are of the speakers alone.<br /><br />Further information about the workshops including further outputs can be found here: <a href="https://www.sanger.ac.uk/innovation/sanger-genomics-futures-series/" target="_blank" rel="noreferrer noopener">https://www.sanger.ac.uk/innovation/sanger-genomics-futures-series/</a><br /><br />This podcast is produced by the Wellcome Sanger Institute.
Language
🇺🇲
Publishing Since
4/14/2026
1 verified contact email on file for Genomics Futures
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 19, 2026
Health
The final episode of the #GenomicsFutures podcast focuses on how genomics can change patient care over the next 25 years.<br /><br />In the last 100 years, genetics and genomics have transformed our understanding of the human body. We have mapped thousands of genes and discovered the origins of around 80% of rare conditions, yet most insights have not translated into real patient benefit. In this episode, we talk about how this could change, including: <br /><ul><li>A move towards pre-emptive and predictive healthcare, where diagnosis will shift from identifying clinical symptoms to defining diseases by their underlying molecular pathology, ending trial-and-error treatments. Technology may also help detect abnormal biological pathways and prompt clinical action before a patient even feels sick.</li><li>The need to capture global diversity in our data to ensure that people globally can benefit from advances in genomics. </li><li>How we can use genomics to accelerate the success rate of drug discovery.</li></ul><br /><br />This episode includes interviews with: <br /><ul><li>Professor Carl Anderson, Head of the Human Genetics programme at the Wellcome Sanger Institute</li><li>Professor Rachel Freathy, Lecturer in Human Genetics at Exeter University </li><li>Professor Soo Teo, Chief Scientific Officer of Cancer Research Malaysia</li><li>Dr Alejandra Medina Rivera, Principal Investigator at the Regulatory Genomics and Bioinformatics laboratory in Mexico</li><li>Professor Zane Lombard, Academic Head of Human Genetics at the University of the Witwatersrand</li><li>Dr Rob Scott, Vice President of Human Genetics at GSK</li><li>Dr Gosia Trynka, Science Director at Open Targets and Group Leader at the Wellcome Sanger Institute</li></ul><br /><br />Further information on topics discussed in the episode:<br /><ul><li><a href="https://ourfuturehealth.org.uk/" target="_blank" rel="noreferrer noopener">Our Future Health</a> – an ambitious collaboration between the public, charity and private sectors in the UK to build the UK’s largest health research programme</li><li><i>BRCA1/2 </i>– BReast CAncer gene 1 and BReast CAncer gene 2, genes that when altered can significantly increase the risk of breast and ovarian cancers, among other cancers.</li><li><a href="https://www.gov.uk/government/publications/digital-twin-definition/digital-twin-official" target="_blank" rel="noreferrer noopener">Digital twin</a> – a virtual replica of a biological entity or process. It can use real-time data to simulate, predict and optimise outcomes.</li><li>Human Genome Project – a landmark 13-year international research effort (1990 to 2003) that successfully mapped and sequenced the entire human genetic blueprint.</li><li><a href="https://h3africa.org/" target="_blank" rel="noreferrer noopener">H3Africa</a> – Human Heredity and Health in Africa, was formally launched in 2012 in <a href="https://en.wikipedia.org/wiki/Addis_Ababa" target="_blank" rel="noreferrer noopener">Addis Ababa</a> and has grown to include research projects across 32 countries, a pan-continental bioinformatics network, and the first <a href="https://en.wikipedia.org/wiki/Whole_genome_sequencing" target="_blank" rel="noreferrer noopener">whole genome sequencing</a> of many African <a href="https://en.wikipedia.org/wiki/Ethnolinguistic_group" target="_blank" rel="noreferrer noopener">ethnolinguistic groups</a>.</li></ul><br /><br />25 years on from the release of the first draft of the human genome, the Genomics Futures podcast series explores what the future of genomics will be like in 2050.<br />Across 6 episodes, we explore the themes and topics that arose from discussions that took place during the Genomics Futures workshops, hosted by the Wellcome Sanger Institute and Wellcome in 2025.<br /><br />The aim of these podcasts is not to showcase definitive thoughts, but to explore the possibilities of genomics in twenty five years’ time, hence why some speakers may contradict each other....
May 12, 2026
Impact
The fifth episode of the #GenomicsFutures podcast focuses on the impact new technologies could have over the next 25 years, and what is needed to ensure everyone benefits from these.<br /><br />Science is evolving, with things such as AI and other new technologies that could radically reshape the research landscape. This episode dives deeper into what this might lead to, covering topics such as:<br /><ul><li>Data as the primary substrate: Discovery is no longer just downstream of experiments; foundational data resources (like biobanks) are becoming the place from which all future research flows.</li><li>Continuous wearable monitoring: The future of research involves moving away from episodic sampling toward dense longitudinal monitoring through wearables, allowing for predictive and preventative medical interventions.</li><li>Decolonising research funding: Equity requires dismantling extractive practices and shifting power so that regional institutions hold the governance for their own programmes and set their own priorities.</li><li>Reproducibility through automation: Standardised automation is essential for global reproducibility, ensuring that experiments performed in different parts of the world yield consistent results for AI training.</li></ul>This episode includes interviews with: <br /><ul><li>Professor Matt Hurles, Director of the Wellcome Sanger Institute.</li><li>Dr Tariq Khokhar, Head of Data for Science and Health at Wellcome.</li><li>Dr Dana Cortade, Project Manager at the Align Foundation.</li><li>Dr Denis Chopera, Senior Programme Manager at the Leadership for African Research Networks (LEARN R&D)</li><li>Dr Sophie Gilbert, Programme Lead at the Geneva Science and Diplomacy Anticipator (GESDA).</li></ul><br />Links to things mentioned in the episode:<br /><ul><li><a href="https://zenodo.org/records/15367758" target="_blank" rel="noreferrer noopener">GROQ-seq platform</a> – A project managed by the Align foundation.</li><li><a href="https://www.ukbiobank.ac.uk/" target="_blank" rel="noreferrer noopener">UK Biobank</a> – A long-term prospective <a href="https://en.wikipedia.org/wiki/Biobank" target="_blank" rel="noreferrer noopener">biobank</a> study in the United Kingdom that houses the de-identified biological samples and health-related data of half a million people.</li><li><a href="https://www.gov.uk/government/publications/digital-twin-definition/digital-twin-official" target="_blank" rel="noreferrer noopener">Digital twin</a> – A virtual replica of a biological entity or process. It can use real-time data to simulate, predict and optimise outcomes.</li><li><a href="https://www.mlw.mw/" target="_blank" rel="noreferrer noopener">MLW</a> – The Malawi-Liverpool Wellcome Trust Clinical Research Programme (MLW) is built around excellent laboratories, strategically located in the largest hospital in Malawi, Queen Elizabeth Central Hospital, which is closely linked with the community and an integral part of the medical school.</li><li><a href="https://africacdc.org/" target="_blank" rel="noreferrer noopener">Africa CDC</a> – The Africa Centres for Disease Control and Prevention (CDC) is a public health agency of the African Union to support the public health initiatives of member states and strengthen the capacity of their health institutions to deal with disease threats.</li><li><a href="https://www.nist.gov/" target="_blank" rel="noreferrer noopener">NIST</a> – The National Institute of Standards and Technology (NIST) is an agency of the <a href="https://en.wikipedia.org/wiki/United_States_Department_of_Commerce" target="_blank" rel="noreferrer noopener">United States Department of Commerce</a> whose mission is to promote American innovation and industrial competitiveness.</li><li>LDL – Low-density lipoprotein (LDL) cholesterol is often referred to as “bad cholesterol” because it can build up in arteries if levels are too high, increasing the risk of health issues.</li></ul><br /><br />25 years on from...
May 5, 2026
Life on Earth
The fourth episode of the #GenomicsFutures podcast series focuses on the future of environmental genomics!<br /><br />Genomics could transform how we protect life on Earth, but big challenges remain. This episode covers topics including:<br /><ul><li><b>Genomics for climate resilience:</b> Genomic information is seen as a critical catalyst for mitigating climate change impacts, particularly in developing resilient crops to ensure global food security.</li><li><b>Real-time biomonitoring:</b> Future tools, such as handheld "tricorders" or autonomous marine samplers, could provide real-time dashboards of ecosystem health, flagging disease outbreaks or invasive species before they become crises.</li><li><b>Indigenous knowledge and sovereignty:</b> Integrating indigenous knowledge and ensuring data sovereignty are essential, making local communities equal partners in research and benefit-sharing.</li><li><b>Functional biodiversity:</b> Rather than just saving single species, the focus is shifting toward restoring the functions and connectivity of entire ecosystems to make them self-sustaining and resilient.</li></ul>This episode includes interviews with:<br /><ul><li>Dr Mark Blaxter, Head of the Tree of Life programme at the Wellcome Sanger Institute, and Dr Alan Dangour, Director of Climate and Health at Wellcome.</li><li>Dr Federica Di Palma, Vice President of Genome British Columbia, talks about bioprospecting and data sovereignty.</li><li>Professor Rasmus Grondfeldt Winther, from the University of California, Santa Cruz and the University of Copenhagen, speaks about climate resilience and ethics.</li><li>Dr ThankGod Ebenezer, Global Engagement Manager at EMBL’s European Bioinformatics Institute, discusses the future of biodiversity and biomonitoring.</li><li>Dr Roksana Majewska, marine researcher at Nord University in Norway, and Professor Maui Hudson, co-director of the Te Kotahi Research Institute in New Zealand, explore restructuring degraded ecosystems and the role of indigenous knowledge in science. </li></ul><br /><br />More information about things mentioned in this episode:<br /><ul><li><a href="https://www.earthbiogenome.org/" target="_blank" rel="noreferrer noopener">Earth BioGenome Project</a> – a project aiming to sequence, catalog and characterise the genomes of all of Earth’s eukaryotic biodiversity over a period of ten years.</li><li><a href="https://africanbiogenome.org/" target="_blank" rel="noreferrer noopener">African BioGenome project</a> – A coordinated pan-African effort to build capacity (and infrastructure) to generate, analyze and deploy genomics data for the improvement and sustainable use of biodiversity and agriculture across Africa.</li><li><a href="https://www.sanger.ac.uk/collaboration/ancient-environmental-genomics-initiative-for-sustainability-aegis/" target="_blank" rel="noreferrer noopener">Ancient Environmental Genomics Initiative for Sustainability (AEGIS)</a> – a global consortium led by the <a href="https://globe.ku.dk/" target="_blank" rel="noreferrer noopener">Globe Institute</a> at the University of Copenhagen. AEGIS aims to develop the essential science and methodology to use ancient environmental DNA (eDNA) – coupled with other ancient and modern biomolecule-based approaches – to identify important organismal associations and genetic adaptations in natural and agro-ecosystems that will improve future food security under climate change.</li><li><a href="https://unfccc.int/process/bodies/supreme-bodies/conference-of-the-parties-cop" target="_blank" rel="noreferrer noopener">Conference of the Parties (COP)</a> – the supreme decision-making body of an international convention.</li><li>Benefits sharing – a concept referring to the equitable distribution of advantages derived from the use of resources, particularly in contexts like genetic resources, community projects, and environmental conservation.</li><li><a href="https://www.erga-biodiversity.eu/" target="_blank" rel="noreferrer...
7 total episodes available
Deep-dive analytics for Genomics Futures
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Genomics Futures?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.